More interestingly, although apoptosis is taken as a barrier to carcinogenesis and resistance to apoptosis is regarded as a hallmark of cancer, the overexpression of the antiapoptotic oncogene Bcl-2 was an indicator of favorable prognosis in breast cancer, colon cancer, and non-small cell lung cancers. This evidence concerns the gene BCL2 and colonic neoplasm.